CIK 0000725363
- Non-accelerated filer
- Smaller reporting company
CEL SCI CORP
Sign in to watch- Ticker
- CVM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- CO
- Entity type
- Operating
- EIN
- 840916344
- Phone
- +1 703-506-9460
- Business address
- 8229 BOONE BLVD ., SUITE 802, VIENNA, VA, 22182
- Open-market buys, last 90 days
- $138,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$138,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-11 | KERSTEN GEERT R CEO | Option exercise | +109,170 | $2.29 | $250K | 762,123 |
| 2018-06-11 | KERSTEN GEERT R CEO | Option exercise · Convertible Note | −147,929 | $250,000.00 | $37.0B | 1,463,633 |
| 2018-06-11 | KERSTEN GEERT R CEO | Grant or award · Series UU Warrants | +29,586 | $0.01 | $296 | 1,493,219 |
| 2018-06-11 | KERSTEN GEERT R CEO | Option exercise · Convertible Note (1) | −109,170 | $250,000.00 | $27.3B | 1,384,049 |
| 2018-06-11 | KERSTEN GEERT R CEO | Grant or award · Series UU Warrants (1) | +21,834 | $0.01 | $218 | 1,405,863 |
| 2018-06-04 | YOUNG PETER R Director | Option exercise | +2,400 | $1.75 | $4K | 16,091 |
| 2018-06-04 | YOUNG PETER R Director | Option exercise · Series S Warrants | −60,000 | $10,715.00 | $642.9M | 129,200 |
| 2018-06-01 | KERSTEN GEERT R Chief Executive Officer | Option exercise | +14,760 | $1.75 | $26K | 505,024 |
| 2018-06-01 | KERSTEN GEERT R Chief Executive Officer | Option exercise · Series S Warrants | −369,000 | $132,795.00 | $49.0B | 1,611,562 |
| 2018-05-01 | Watson Robert Eugene Director | Grant or award · Options | +80,000 | $0.01 | $800 | 90,000 |
| 2018-05-01 | BAILLAVOINE BRUNO JEAN-MARIE Director | Grant or award · Options | +80,000 | $0.01 | $800 | 117,500 |
| 2018-05-01 | YOUNG PETER R Director | Grant or award · Options | +80,000 | $0.01 | $800 | 129,200 |
| 2018-05-01 | CIPRIANO JOHN Senior Vice President | Grant or award · Options | +13,347 | $0.01 | $133 | 108,547 |
| 2018-05-01 | CIPRIANO JOHN Senior Vice President | Grant or award · Options | +135,000 | $0.01 | $1K | 243,547 |
| 2018-05-01 | ZIMMERMAN DANIEL H Senior Vice President | Grant or award · Options | +26,194 | $0.01 | $262 | 72,694 |
| 2018-05-01 | ZIMMERMAN DANIEL H Senior Vice President | Grant or award · Options | +100,000 | $0.01 | $1K | 172,694 |
| 2018-05-01 | PRICHEP PATRICIA B Senior Vice President | Grant or award · Options | +42,607 | $0.01 | $426 | 216,968 |
| 2018-05-01 | PRICHEP PATRICIA B Senior Vice President | Grant or award · Options | +180,000 | $0.01 | $2K | 396,968 |
| 2018-05-01 | TALOR EYAL Chief Scientific Officer | Grant or award · Options | +13,934 | $0.01 | $139 | 159,497 |
| 2018-05-01 | TALOR EYAL Chief Scientific Officer | Grant or award · Options | +180,000 | $0.01 | $2K | 339,497 |
Page 13 of 17 · 329 trades